期刊文献+

老年直肠癌临床特征及治疗的变迁

Change of the clinical features and treatments of the elderly rectal carcinoma.
下载PDF
导出
摘要 目的 了解近年来老年直肠癌临床特征及治疗的变迁。方法 回顾性分析 10年间 313例老年直肠癌患者的临床特征及治疗情况 ,对比第一个 5年和第二个 5年的临床特征及治疗方法的变迁。结果 发病年龄后延 ,误诊率降低 ,早期病例增多 ;Dixon手术增多 ,辅助治疗由简单变为综合治疗方法 ;5年生存率明显提高 ,术后的复发率明显减低。结论 老年直肠癌发病年龄后延 ,误诊率降低 ,早期病例逐渐增多 ;治疗上更趋有效、合理。 Objective To investigate the changes of the clinical features and treatments of the elderly rectal carcinoma. Methods All 313 cases of the elderly rectal carcinoma in 10 years were identified and analyzed retrospectively, compare the changes of clinical features and treatment strategy between the first five years and the later five years. Results The age of onset was delaying, the early cases and peak age of the elderly rectal carcinoma increased, but misdiagnosis rate decreased.The Dixon's operation increased and the adjuvant treatments changed from the simple therapy to the combined . In the recent 5 year, the 5-year survival rate of elderly rectal carcinoma significantly increased and the recurrence rate obviously decreased Conclusion The early cases and peak age of the elderly rectal carcinoma increased, but misdiagnosis rate decreased and the therapy became more reasonable.
出处 《现代肿瘤医学》 CAS 2004年第4期318-320,共3页 Journal of Modern Oncology
关键词 老年 直肠癌 手术 辅助治疗 临床特征 elderly rectal carcinoma surgery adjuvant treatments clinical features
  • 相关文献

参考文献5

二级参考文献39

  • 1莫善兢.大肠癌流行病学与普查研究进展[J].实用肿瘤杂志,1993,8(3):181-183. 被引量:7
  • 2黄建,吴金民,杨工,张苏展,余海,郑树.结直肠癌临床病理参数预后意义的多因素Cox回归分析[J].中国肿瘤临床,1996,23(3):156-162. 被引量:24
  • 3张一心,陈拓.直肠癌局部切除术22例分析[J].交通医学,1996,10(2):63-64. 被引量:1
  • 4郭俊超,邱辉忠.老年人直肠癌的诊治特点[J].腹部外科,1997,10(1):3-5. 被引量:19
  • 5战中利 闫庆娜 邱志强 见:郝希山 王殿昌.大肠肿瘤病理学[A].见:郝希山,王殿昌.腹部肿瘤学[C].北京:人民卫生出版社,2003.340-352.
  • 6[1]Wong CS,Cummings,et al. Treatment of locally recurrent rectal carcinomar-result and pronostic factors. Int J Radiation oncol Biol Phys,1998,40:427-435.
  • 7[2]QUASAR Collaborative Group. Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer:a randomised trial. Lancet, 2000:1588-1596.
  • 8[3]Shibata M, Nezu T, et al. Immunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer. Cancer Invest,2002, 20:166-173.
  • 9[4]Cheeseman SL, Joel SP, et al. A modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. Br J Cancer, 2002 ,87:393-399
  • 10[5]Grem JL, Quinn M, et al Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion. Cancer Chemother Pharmacol, 2001,47:117-125.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部